|Global Edition

S&P 500 7,165 +0.38%NASDAQ 24,837 +0.73%BTC $77,327 -0.35%ETH $2,312 -0.32%SOL $85.78 -0.69%EUR/USD 1.1726 +0.17%GOLD 4,741 +0.76%S&P 500 7,165 +0.38%NASDAQ 24,837 +0.73%BTC $77,327 -0.35%ETH $2,312 -0.32%SOL $85.78 -0.69%EUR/USD 1.1726 +0.17%GOLD 4,741 +0.76%

GlobalMarkets

Today

Finance

Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free

Regeneron is the latest in a string of major drugmakers to make pricing concessions for new and existing medicines under agreements with Trump.

CNBC

April 24, 2026· 1 min read

Finance

Regeneron is the latest in a string of major drugmakers to make pricing concessions for new and existing medicines under agreements with Trump.

Original article

Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free

Published by CNBC

Read full article